Could a Blood Test Help Clinicians Diagnose Multiple Myeloma Earlier?
Levels of hemoglobin, combined with ESR, PV, and calcium values, were determined to be the blood parameters with the most diagnostic value in multiple myeloma.
Archive
Brachytherapy Recommended for Treatment of Penile Cancer
Brachytherapy “is the treatment of choice” for men with penile carcinoma whose cancer has not spread to the corpus cavernosum.
Papillary Thyroid Cancer: Radiographic SLNB May Lead to Management Change
The use of the radioguided sentinel lymph node biopsy (rSLNB) technique may lead to management change in more than 33% of patients with papillary thyroid cancer.
Regorafenib May Improve PFS for Patients With Metastatic Sarcoma
Regorafenib provides a statistically significant benefit for non-liposarcoma patients with pre-treated, metastatic sarcoma.
T-VEC Plus Ipilimumab for Advanced Melanoma Appears More Beneficial Than Monotherapy
Talimogene laherparepvec (T-VEC), an oncolytic virus, in conjunction with ipilimumab, an immune checkpoint inhibitor, may be more beneficial than either agent alone for patients with advanced melanoma.
Tasquinimod Improves rPFS for Patients with Metastatic Castration-Resistant Prostate Cancer
Tasquinimod improved radiographic progression-free survival (rPFS) in contrast with placebo in chemotherapy-naïve men with mCRPC.
Adjuvant Chemo With S-1 Effective for Resected Pancreatic Cancer in Japanese Patients
Adjuvant chemotherapy with S-1 may improve standard of care for Japanese patients with resected pancreatic cancer.
Adding Olaratumab to Doxorubicin Improves Survival in Soft-tissue Sarcoma
Addition of olaratumab to doxorubicin significantly improves PFS and OS in patients with advanced soft-tissue sarcoma.
Twins Study Suggests Strong Familial Risk for Testicular Cancer
A study of twins with 22 980 individuals suggested that the familial risk for testicular cancer may be dramatically underestimated.
Leukocyte Expression Linked with Penile Cancer Outcomes
Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer.
Want to read more?
Please login or register first to view this content.